personalized medicine

Picture every blood test as a dot on a large map. Plot thousands of those dots and they won't scatter at random: they line up along two main roads. One road separates men from women, the other stretches from youth to old age. Follow these roads and you can see how a person grows up, lives and grows old.

A watchdog that yawns and turns away instead of barking at an intruder is a bad guard. That is roughly how CD8+ T cells behave in people with type 2 diabetes. These cells are professional killers: they patrol the body, find infected or cancerous cells, and destroy them. But in diabetes, something breaks in the recognition system itself, and the watchdogs stop recognizing the enemy.

Every one of us has wondered at least once how many years we'll live. In 1996, nearly two and a half thousand Japanese people over sixty answered that question in a national survey. Their answers became a kind of mirror reflecting hopes, fears, and habits of thought. Twenty-eight years later, researchers compared those forecasts with actual dates of death and found that the mirror was warped, but not useless.

In 2023, in Belgium, 101 people aged 50 to 69 spent several days in a lab where their brains were scanned, their sleep was recorded, and they were asked to solve memory and attention tasks. That is how the COFITAGE dataset was born, describing each participant from five angles: molecular, structural, physiological, genetic and cognitive.

A drop of blood on filter paper preserves not only cells but also a record of what has been happening to the body over the past few months. That record is not in the genes but on them: the chemical marks cells attach to DNA change with food, stress, illness and age. Scientists have learned to read this archive tape to reconstruct a picture of health without repeated trips to the lab.

At the end of every chromosome sits a cap made of repeating DNA letters: the telomere. For a long time it was measured as an average length across all chromosomes, as if judging a library by the average thickness of its books. But in humans, three ends, 17p, 20q, and 12p, are consistently shorter than the rest, and they are the ones more often linked to genome damage.

Each morning, a navigator plots a route, bypassing traffic jams and roadblocks. Similarly, before a radiation therapy session, a new AI agent recalculates the irradiation path.

When a pipe bursts in the basement, a plumber acts step by step: locates the leak, measures the pressure, determines the cause, patches it up, and checks if it's dry. The same recipe — the standard model DMAIC — is being proposed against epidemics. First, they determine the scope — how many hospital beds are occupied, which industries are sagging.

Inside each of us, invisible clocks are ticking. They control the release of cortisol — the hormone that helps us wake up in the morning, cope with anxiety, and keep our immune system on its toes. In adrenal insufficiency, these clocks break down: the body can't produce the right amount of cortisol on its own.

On the screen is the result of a complex simulation: two planets collided, a shockwave ripples outward. A couple of clicks in an editor, and harsh shadows soften, noise smooths out, the background darkens. This kind of digital retouching (image editing to enhance appearance) has long been part of the scientist’s toolkit.

Every week, doctors ask AI assistants millions of questions at the bedside. But these tools are usually tested on exam-style problems, not on what clinicians actually ask in practice. A team of researchers set out to fix that. They collected 620 real questions from physicians across 30 specialties — from cardiology to oncology.

An engineer tunes an antenna: pull one segment, the frequency drifts; change the angle, the gain drops. Developing therapeutic peptides (short protein chains) works much the same way.

You buy a new kitchen scale, but instead of exact weight, it only shows deviations from some "norm." To find out how much an apple weighs, you first have to weigh dozens of other apples and calculate the average.

An engineer building a bridge cannot strengthen one beam without affecting the load on adjacent ones. Drug development works similarly: a molecule must fit snugly into the 'pocket' of a target protein, like a key in a lock, while also being safe, stable, and convenient to administer.

A social network is like a city: there are giant neighborhoods and tiny alleys. When an algorithm looks for tight-knit groups, it often picks out a couple of huge clusters and many small fragments. But the client (say, a municipality) needs districts of roughly equal size to distribute clinics or schools evenly.

For one person, the disease begins with a tremor in the hand — the cup dances on its saucer as they carry it to the table. For another, the legs suddenly refuse to move smoothly: the step becomes short and shuffling, as if the floor were suddenly covered in a sticky layer. These are not two different diseases but two faces of the same one — Parkinson's disease.

In a car, the steering, brakes, and accelerator gradually fail. At first, you can still swerve around a pothole, but each year the maneuver takes more effort. At some point, even a perfect road becomes impassable — the car no longer obeys the driver. That's exactly how the authors describe aging: not as the accumulation of rust or wear and tear, but as the loss of "controllability" of the body.

A biologist looks through a microscope at dozens of tiny cell spheres — spheroids. From these, miniature organ-like structures will later grow. The task is similar to a baker's job of checking whether the dough has risen evenly in each mold. Only here, instead of molds, there's a nutrient medium, and instead of dough, there are living cells.

The microbial community in the gut is like an orchestra: what matters is not only the musicians but how they play together. When disease strikes, it's not just the lineup of microbes that changes: their interconnections shift too. Researchers built interaction networks of microbial genes in healthy and sick individuals.

A drop of blood from a fingertip is like a photograph. One is just a snapshot, but collect them over years and you get a movie of your health.

Brain aging is like the wear and tear on a bridge: cracks appear unnoticed, but if you reinforce the supports in time, the structure lasts longer. Three ordinary things turned out to be such supports — handgrip strength, the ability to move for a long time without breathlessness, and lung capacity.

A typical medical neural network sees a patient as a point on a map: there's height, blood pressure, a blood test, and the model places a single label: "healthy" or "sick." But in a real hospital, the map is always torn. One test is done on Monday, another a month later, and the CT scanner is a different brand altogether. A point on such a map is self-deception.

The brain of a person with Parkinson's disease works like an orchestra where the conductor either freezes or waves the baton off-beat. Medications don't help everyone, so doctors turn to stimulation — weak electrical pulses that restore the rhythm.

When treating prostate cancer, doctors often see not one tumor but many lesions in bones and lymph nodes. Each lesion can respond to therapy differently: one shrinks, another stays the same, a third grows. Previously, the disease was assessed as a whole, like judging the weather by the average temperature over a year.

Previously, generative models for drug discovery worked like an artist painting without choosing a canvas. They learned from existing molecules and simply produced similar ones, without considering how the space of possible compounds is organized. SpaceGFN changes the approach: now chemical space is a construction set where the user specifies the parts and the assembly rules.

You can edit a cell perfectly, and it still turns out useless. The gene is fixed exactly as planned, yet the cell behaves unpredictably: it drifts, changes fate, loses safety. It's like fixing one gear in a watch, but the watch still runs wrong because the whole mechanism is out of sync. Previously, a cell was viewed as a list of independent parts.

Inside our bodies, between cells, there is a support network — the extracellular matrix. It's like scaffolding made of proteins and carbohydrates that holds cells in place. When the fibers in this network change, it can be a sign of disease — for example, cancer or fibrosis. Usually, to see these fibers, tissue is cut into thin slices and stained with special dyes.

A brain tumor is like a traveler trudging through a dense forest: trees and bushes are the different types of brain tissue, some easier to traverse than others. Glioma cells don't move in a straight line; they constantly loop around, bumping into obstacles and going around them.

A chemist searching for a new drug is like a cook without a recipe: they have a list of desired properties but millions of possible ingredients. Each trial is costly and time-consuming, so you need to experiment wisely. The new program SEISMO acts like a chef who tastes the dish after every step and immediately decides what to add next.

A detective is looking for a criminal in a file of mugshots, but the portraits are mixed up. Usually, they expect a man with a gray beard, but the culprit is young and clean-shaven. Similarly, doctors often fail to recognize Alzheimer's disease in those who show unusual symptoms — not memory loss, but problems with vision or speech.

Computed tomography is like an X-ray that takes hundreds of images from different angles and stitches them into a 3D picture of the body. But each image delivers a small dose of radiation, and doctors need to know how much each organ receives. Currently, this is often estimated roughly using average tables rather than for the specific patient.

Fog thickens over the line "def max(a: Int, b: Int): Int". What does it do? It returns the larger of two numbers, but how can you verify that? You could write a dozen tests with specific pairs: max(2,3)=3, max(5,5)=5, max(-1,0)=0. Still, a nagging doubt remains: what if it breaks for, say, a million and minus a million?